🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 151 of 151

  1. triheptanoin

    Ultragenyx UK Limited

    Rett Syndrome

    phase 2 small molecule active

    1 trial

  2. trihexyphenidyl

    United Therapeutics Europe Ltd

    Dystonia

    phase 2 small molecule completed

    1 trial

  3. troxacitabine

    Takeda

    Leukemia

    phase 2 small molecule completed

    1 trial

  4. tulisokibart, Placebo to MK-7240

    Merck Sharp and Dohme

    Psoriatic arthritis​​

    phase 2 small molecule active

    1 trial

  5. tulisokibart, Placebo to MK-7240 (tulisokibart)

    Merck Sharp and Dohme

    Rheumatoid Arthritis

    phase 2 small molecule active

    1 trial

  6. two-drug chemotherapy containing platinum, including carboplatin/Cisplatin + pemetrexed/docetaxel/paclitaxel/etoposide/gemcitabine/vinorelbine/albumin-bound paclitaxel

    Shanghai Chest Hospital

    NSCLC

    phase 2 small molecule active

    1 trial

  7. ulodesine

    Biocryst

    Gout

    phase 2 small molecule completed

    1 trial

  8. umbilical cord blood (hUCB) cells

    S.L

    Cerebral Palsy

    phase 2 mab completed

    1 trial

  9. umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cartilage Damage

    phase 2 mab active

    1 trial

  10. umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral Arterial Disease

    phase 2 mab completed

    1 trial

  11. unrelated umbilical cord blood

    The First People's Hospital of Lianyungang

    Myelodysplastic Syndromes

    phase 2 small molecule active

    1 trial

  12. vadadustat

    Akebia Europe Limited

    Acute Respiratory Distress Syndrome

    phase 2 small molecule completed

    1 trial

  13. valoctocogene roxaparvovec

    BioMarin Pharmaceutical Australia Pty Ltd

    Severe Haemophilia A

    phase 2 mab completed

    1 trial

  14. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Alcoholism

    phase 2 small molecule completed

    1 trial

  15. velaglucerase alfa

    Takeda

    Gaucher Disease, Type 3

    phase 2 mab completed

    1 trial

  16. velusetrag dose 1

    Theravance Biopharma Ireland Umited

    Gastroparesis

    phase 2 small molecule completed

    1 trial

  17. veneclax, chidaniline combined with azacitidine (VCA) followed by decitabine + MAG regimen (D-MAG)

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  18. venglustat GZ402671 - SAR402671, IMIGLUCERASE, venglustat GZ402671 - SAR402671

    Genzyme Europe B.V.

    Gaucher disease type 3, Gaucher disease type 1

    phase 2 small molecule active

    1 trial

  19. vidutolimod

    Regeneron UK Limited

    Merkel Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  20. vigabatrin

    CATALYST PHARMACEUTICALS, INC.

    Cocaine Dependence

    phase 2 small molecule completed

    2 trials

  21. vilamakitug

    XBiotech Germany GmbH

    Axial Spondyloarthritis

    phase 2 small molecule active

    1 trial

  22. vilastobart (XTX101)

    Xilio Therapeutics

    Advanced Solid Tumor

    phase 2 small molecule active

    1 trial

  23. vinflunine

    Bristol-Myers Squibb

    Transitional Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  24. vistusertib (AZD2014)

    Samsung Bioepis NL B.V.

    Small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  25. vitamin C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule completed

    1 trial

  26. vitamin C

    CNS Pharmaceuticals

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  27. volrustomig, Monalizumab

    Pari Pharma GmbH

    cancerology

    phase 2 small molecule active

    1 trial

  28. vortioxetine (Lu AA21004)

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  29. vosoritide

    BioMarin Pharmaceutical Australia Pty Ltd

    Achondroplasia

    phase 2 mab active

    1 trial

  30. widow spider antivenom

    BRIGHT MINDS BIOSCIENCES INC.

    Arachnidism

    phase 2 mab completed

    1 trial

  31. xue-fu-zhu-yu capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Qi Stagnation and Blood Stasis Syndrome

    phase 2 small molecule completed

    1 trial

  32. zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antiphospholipid Syndrome

    phase 2 small molecule active

    1 trial

  33. zelicapavir

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 2 small molecule active

    1 trial

  34. zigakibart

    Novartis Pharmaceuticals

    Immunoglobulin A Nephropathy (IgAN)

    phase 2 mab active

    1 trial

  35. zinc supplementation

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 small molecule completed

    1 trial

  36. zoledronic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Congenital Dyserythropoietic Anemia (CDA)

    phase 2 small molecule active

    1 trial

  37. zonisamide

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  38. zorevunersen (STK-001)

    Stoke Therapeutics

    Dravet Syndrome

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.